Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Yaokun, Chen"'
Autor:
Yiyuan Liu, Jinyao Wu, Zeqi Ji, Lingzhi Chen, Juan Zou, Jiehua Zheng, Weixun Lin, Jiehui Cai, Yaokun Chen, Daitian Zheng, Yexi Chen, Zhiyang Li
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background This network meta-analysis aimed to assess the comparative efficacy and safety of combinations involving three cyclin-dependent kinase 4/6 (CDK4/6) inhibitors and endocrine therapies (ETs) in patients with metastatic or advanced b
Externí odkaz:
https://doaj.org/article/801b5bf6496543cdbfd3a5e49679b710
Autor:
Jinyao Wu, Yaokun Chen, Lingzhi Chen, Zeqi Ji, Huiting Tian, Daitian Zheng, Qiuping Yang, Yiyuan Liu, Jiehui Cai, Jiehua Zheng, Yexi Chen, Zhiyang Li
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
In recent years, anti-PD-1/anti-PD-L1 has been considered to be a valuable therapeutic target and prognostic indicator for triple-negative breast cancer. We analyzed all publications published in the field from their inception until the present day i
Externí odkaz:
https://doaj.org/article/9f13d1d7cd6c40e68f017158c7c0c486
Autor:
Jiehui Cai, Zeqi Ji, Jinyao Wu, Lingzhi Chen, Daitian Zheng, Yaokun Chen, Xinkang Zhang, Wanchun Xie, Jieying Huang, Manqi Chen, Ru Lin, Weixun Lin, Yexi Chen, Zhiyang Li
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Breast cancer (BC), the most common malignancy in women, has a high cancer-related mortality. Endoplasmic reticulum stress (ERS), a response to the accumulation of unfolded proteins, has emerging roles in tumorigenesis, including invasion, metastasis
Externí odkaz:
https://doaj.org/article/5d8f5b2cb1924e2f8273203a4b476113
Autor:
Zhiyang Li, Jiehua Zheng, Zeqi Ji, Lingzhi Chen, Jinyao Wu, Juan Zou, Yiyuan Liu, Weixun Lin, Jiehui Cai, Yaokun Chen, Yexi Chen, Hai Lu
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Background and ObjectivePrevious studies determined the therapeutic effects of capecitabine-based chemotherapy regimens on early-stage triple-negative breast cancer (TNBC). However, the optimal strategy of capecitabine-based chemotherapy remains unce
Externí odkaz:
https://doaj.org/article/cc7bf0f4ceaf4926ad73067af04b71f2
Autor:
Qi Wang, Yaokun Chen, Wen Gao, Hui Feng, Biyuan Zhang, Haiji Wang, Haijun Lu, Ye Tan, Yinying Dong, Mingjin Xu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundLung squamous cell carcinoma (LUSC) represents 30% of all non-small cell lung carcinoma. Targeted therapy is not sufficient for LUSC patients because of the low frequency of targeted-effective mutation in LUSC whereas immunotherapy offers m
Externí odkaz:
https://doaj.org/article/a37c10cab0574f4d80572defdffbbf85
Autor:
Lingzhi Chen, Yiyuan Liu, Jiehui Cai, Zeqi Ji, Juan Zou, Yaokun Chen, Jinyao Wu, Daitian Zheng, Jiehua Zheng, Yexi Chen, Zhiyang Li
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Recently, the androgen receptor has been found as a potential prognostic index and therapeutic target for breast cancer. To reveal the current research status and hotspots in this area, we analyzed the characteristics of related publications from 201
Externí odkaz:
https://doaj.org/article/31b16399886b4122910631ac9f31f4c7
Autor:
Taofeng Zhang, Yihuan Chen, Weixun Lin, Jiehua Zheng, Yiyuan Liu, Juan Zou, Jiehui Cai, Yaokun Chen, Zhiyang Li, Yexi Chen
Publikováno v:
Frontiers in Genetics, Vol 12 (2021)
Thyroid cancer (THCA) is a common endocrine malignancy. With increasing incidence and low mortality, balancing the therapeutic approach is an inevitable issue. This study aimed to confirm the role of miR-222-3p and its target genes in THCA survival a
Externí odkaz:
https://doaj.org/article/c7a5e8aa08e24c50aa4c12da55ffd259
Autor:
Shangbo Xu, Yiyuan Liu, Taofeng Zhang, Jiehua Zheng, Weixun Lin, Jiehui Cai, Juan Zou, Yaokun Chen, Yanna Xie, Yexi Chen, Zhiyang Li
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundThe burden of breast cancer has been increasing globally. The epidemiology burden and trends need to be updated. This study aimed to update the burden and trends of breast cancer incidences, deaths, and disability-adjusted life-years (DALYs
Externí odkaz:
https://doaj.org/article/c9dc02b342464434ad28b953c07e360c
Autor:
Yaokun Chen, Weixun Lin, Xiao-Qi Lin, Yexi Chen, Juan Zou, Zhiyang Li, Jiehui Cai, Jiehua Zheng
Publikováno v:
World Journal of Clinical Cases
BACKGROUND Studies have shown that patients with chronic renal failure (CRF) are more likely to suffer from breast cancer and other malignant tumors. To our knowledge, CRF can reduce drug excretion, thereby increase drug exposure and lead to increase
Publikováno v:
BioMed research international. 2022
Patients with a previous cancer history (PCA) are routinely excluded from most clinical trials, which may limit the accuracy and universality of clinical trials. We aimed to explore the association between PCA and survival of patients with different